| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Biofrontera AG (XETRA: B8F)
B8F Technical Analysis
5
| As on 9th Jun 2023 B8F STOCK Price closed @ 0.86 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.32 & Strong Sell for SHORT-TERM with Stoploss of 1.36 we also expect STOCK to react on Following IMPORTANT LEVELS. |
B8FSTOCK Price
| Open | 0.92 | Change | Price | % |
| High | 0.92 | 1 Day | -0.04 | -4.44 |
| Low | 0.85 | 1 Week | -0.14 | -14.00 |
| Close | 0.86 | 1 Month | -0.35 | -28.93 |
| Volume | 38331 | 1 Year | -0.63 | -42.28 |
| 52 Week High 1.72 | 52 Week Low 0.95 | ||||
XETRA Germany Most Active Stocks
| LHAR | 2.05 | -20.23% |
| BBVA | 5.00 | -2.72% |
| BBVA | 5.00 | -2.72% |
| BBVA | 5.00 | -2.72% |
| BVBA | 0.02 | -60.00% |
| SNH | 0.16 | 6.67% |
| SNH | 0.16 | 6.67% |
| SNH | 0.16 | 6.67% |
| AT1 | 1.15 | 5.50% |
| AT1 | 1.15 | 5.50% |
XETRA Germany Top Gainers Stocks
XETRA Germany Top Losers Stocks
| B8F Daily Charts |
B8F Intraday Charts |
Whats New @ Bazaartrend |
B8F Free Analysis |
|
|
B8F Important Levels Intraday
| RESISTANCE | 0.99 |
| RESISTANCE | 0.95 |
| RESISTANCE | 0.92 |
| RESISTANCE | 0.90 |
| SUPPORT | 0.82 |
| SUPPORT | 0.80 |
| SUPPORT | 0.77 |
| SUPPORT | 0.73 |
B8F Forecast May 2024
| 4th UP Forecast | 1.75 |
| 3rd UP Forecast | 1.46 |
| 2nd UP Forecast | 1.29 |
| 1st UP Forecast | 1.11 |
| 1st DOWN Forecast | 0.61 |
| 2nd DOWN Forecast | 0.43 |
| 3rd DOWN Forecast | 0.26 |
| 4th DOWN Forecast | -0.03 |
B8F Weekly Forecast
| 4th UP Forecast | 1.03 |
| 3rd UP Forecast | 0.98 |
| 2nd UP Forecast | 0.94 |
| 1st UP Forecast | 0.91 |
| 1st DOWN Forecast | 0.81 |
| 2nd DOWN Forecast | 0.78 |
| 3rd DOWN Forecast | 0.74 |
| 4th DOWN Forecast | 0.69 |
B8F Forecast2024
| 4th UP Forecast | 2.54 |
| 3rd UP Forecast | 2 |
| 2nd UP Forecast | 1.67 |
| 1st UP Forecast | 1.33 |
| 1st DOWN Forecast | 0.39 |
| 2nd DOWN Forecast | 0.05 |
| 3rd DOWN Forecast | -0.28 |
| 4th DOWN Forecast | -0.82 |
Biofrontera AG ( XETRA Germany Symbol : B8F )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
B8F Business Profile
Biofrontera AG, a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for the treatment of dermatological conditions and diseases caused primarily by exposure to sunlight that results in sun damage to the skin. Its principal product is Ameluz, a prescription drug for the treatment of lesion-directed and field-directed actinic keratosis. The company also offers BF-RhodoLED lamp, a photodynamic therapy for lesion-directed and field-directed treatment of actinic keratosis; and Belixos, an over-the-counter line of skin care cosmetic products. In addition, it is developing Ameluz for the treatment of field cancerization and nodular basal cell carcinoma. Further, the company's product portfolio includes Xepi, a prescription antibiotic cream for the treatment of impetigo; and Aktipak, a generic drug for the treatment of acne. It offers its products primarily in the United States, Europe, and Israel. The company has a collaboration and partnership agreement with Maruho Co., Ltd. Biofrontera AG was founded in 1997 and is headquartered in Leverkusen, Germany. Address: Hemmelrather Weg 201, Leverkusen, Germany, 51377
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service